InnoCan Pharma Corporation announced the addition of Dr. Kenji Kitatani, to Innocan pharma's Advisory Committee, as an advisor to the Asian markets. Dr. Kenji Kitatani is a leading global media and entertainment business expert with substantial corporate experience and academic expertise.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 CAD | +3.45% | +5.26% | -3.23% |
1st Jan change | Capi. | |
---|---|---|
-3.23% | 59.81M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee